Cargando…

Differential Subcellular Localization Renders HAI-2 a Matriptase Inhibitor in Breast Cancer Cells but Not in Mammary Epithelial Cells

The type 2 transmembrane serine protease matriptase is under tight control primarily by the actions of the integral membrane Kunitz-type serine protease inhibitor HAI-1. Growing evidence indicates that HAI-2 might also be involved in matriptase inhibition in some contexts. Here we showed that matrip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Hsiang-Hua D., Xu, Yuan, Lai, Hongyu, Yang, Xiaoyu, Tseng, Chun-Che, Lai, Ying-Jung J., Pan, Yu, Zhou, Emily, Johnson, Michael D., Wang, Jehng-Kang, Lin, Chen-Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364774/ https://www.ncbi.nlm.nih.gov/pubmed/25786220 http://dx.doi.org/10.1371/journal.pone.0120489

Ejemplares similares

N-Glycan Branching Affects the Subcellular Distribution of and Inhibition of Matriptase by HAI-2/Placental Bikunin
por: Lai, Ying-Jung J., et al.
Publicado: (2015)

Matriptase Complexes and Prostasin Complexes with HAI-1 and HAI-2 in Human Milk: Significant Proteolysis in Lactation
por: Lai, Chih-Hsin, et al.
Publicado: (2016)

Differential subcellular distribution renders HAI-2 a less effective protease inhibitor than HAI-1 in the control of extracellular matriptase proteolytic activity
por: Chiu, Yi-Lin, et al.
Publicado: (2020)

Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin
por: Lee, Shiao-Pieng, et al.
Publicado: (2018)

Correction: Tissue distribution and subcellular localizations determine in vivo functional relationship among prostasin, matriptase, HAI-1, and HAI-2 in human skin
por: Lee, Shiao-Pieng, et al.
Publicado: (2018)

Aberrant regulation favours matriptase proteolysis in neoplastic B-cells that co-express HAI-2
por: Chiu, Yi-Lin, et al.
Publicado: (2019)

Decreasing the ratio of matriptase/HAI-1 by downregulation of matriptase as a potential adjuvant therapy in ovarian cancer
por: Sun, Pengming, et al.
Publicado: (2016)

Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity
por: Tseng, Chun-Che, et al.
Publicado: (2017)

Human Cancer Cells Retain Modest Levels of Enzymatically Active Matriptase Only in Extracellular Milieu following Induction of Zymogen Activation
por: Chu, Li-Ling, et al.
Publicado: (2014)

Regulation of matriptase and HAI-1 system, a novel therapeutic target in human endometrial cancer cells
por: Sun, Pengming, et al.
Publicado: (2018)

Matriptase Autoactivation Is Tightly Regulated by the Cellular Chemical Environments
por: Wang, Jehng-Kang, et al.
Publicado: (2014)

Natural Endogenous Human Matriptase and Prostasin Undergo Zymogen Activation via Independent Mechanisms in an Uncoupled Manner
por: Su, Hui Chen, et al.
Publicado: (2016)

Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation
por: Szabo, Roman, et al.
Publicado: (2012)

Matriptase and prostasin are expressed in human skin in an inverse trend over the course of differentiation and are targeted to different regions of the plasma membrane
por: Lai, Chih-Hsin, et al.
Publicado: (2016)

3‐Cl‐AHPC inhibits pro‐HGF maturation by inducing matriptase/HAI‐1 complex formation
por: Ye, Fang, et al.
Publicado: (2018)

Selective Inhibition of Prostasin in Human Enterocytes by the Integral Membrane Kunitz-Type Serine Protease Inhibitor HAI-2
por: Shiao, Frank, et al.
Publicado: (2017)

Early-onset tufting enteropathy in HAI-2-deficient mice is independent of matriptase-mediated cleavage of EpCAM
por: Szabo, Roman, et al.
Publicado: (2023)

The intracellular seven amino acid motif EEGEVFL is required for matriptase vesicle sorting and translocation to the basolateral plasma membrane
por: Tseng, Chun-Che, et al.
Publicado: (2020)

Matriptase regulates proliferation and early, but not terminal, differentiation of human keratinocytes
por: Chen, Ya-Wen, et al.
Publicado: (2013)

The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals
por: Vogel, Lotte K, et al.
Publicado: (2006)

Antithrombin Regulates Matriptase Activity Involved in Plasmin Generation, Syndecan Shedding, and HGF Activation in Keratinocytes
por: Chen, Ya-Wen, et al.
Publicado: (2013)

Matriptase zymogen supports epithelial development, homeostasis and regeneration
por: Friis, Stine, et al.
Publicado: (2017)

c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase
por: Szabo, Roman, et al.
Publicado: (2011)

Conserved function of the matriptase-prostasin proteolytic cascade during epithelial morphogenesis
por: Drees, Leonard, et al.
Publicado: (2019)

ROS is a master regulator of in vitro matriptase activation
por: Gaymon, Darius O., et al.
Publicado: (2023)

Prolactin-induced Subcellular Targeting of GLUT1 Glucose Transporter in Living Mammary Epithelial Cells
por: Riskin, Arieh, et al.
Publicado: (2015)

Matriptase Deletion Initiates a Sjögren’s Syndrome-Like Disease in Mice
por: Yin, Hongen, et al.
Publicado: (2014)

Inhibition of Matriptase Activity Results in Decreased Intestinal Epithelial Monolayer Integrity In Vitro
por: Pászti-Gere, E., et al.
Publicado: (2015)

Matriptase activation of Gq drives epithelial disruption and inflammation via RSK and DUOX
por: Ma, Jiajia, et al.
Publicado: (2021)

Matriptase promotes inflammatory cell accumulation and progression of established epidermal tumors
por: Sales, Katiuchia Uzzun, et al.
Publicado: (2014)

The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells
por: Steiro, Ida, et al.
Publicado: (2022)

Activated matriptase as a target to treat breast cancer with a drug conjugate
por: Rather, Gulam M., et al.
Publicado: (2018)

Kallikrein 5 Inhibition by the Lympho-Epithelial Kazal-Type Related Inhibitor Hinders Matriptase-Dependent Carcinogenesis
por: da Silva, Elaine Zayas Marcelino, et al.
Publicado: (2021)

Diversity of Matriptase Expression Level and Function in Breast Cancer
por: Welman, Arkadiusz, et al.
Publicado: (2012)

The Impact of Acute Matriptase Inhibition in Hepatic Inflammatory Models
por: Pomothy, Judit, et al.
Publicado: (2016)

Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer
por: Zoratti, Gina L., et al.
Publicado: (2016)

Chronic Alcohol Exposure Renders Epithelial Cells Vulnerable to Bacterial Infection
por: Wood, Stephen, et al.
Publicado: (2013)

Entosis and apical cell extrusion constitute a tumor-suppressive mechanism downstream of Matriptase
por: Armistead, Joy, et al.
Publicado: (2019)

The Effects of Matriptase Inhibition on the Inflammatory and Redox Homeostasis of Chicken Hepatic Cell Culture Models
por: Barna, Réka Fanni, et al.
Publicado: (2021)

Exosome-Mediated Activation of the Prostasin-Matriptase Serine Protease Cascade in B Lymphoma Cells
por: Chen, Li-Mei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ok1jo8o16fceqdm360h9lvtag8